The global vaginitis treatment drug market is experiencing robust growth, with projections indicating a remarkable increase ...

Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcareSanofi and CD&R enter exclusive negotiations to transfer a 50% ...

Earlier in his career, Dr Jupp held senior positions at UCB, Roche and Sanofi where he moved over 10 compounds into clinical development. Dr Jupp holds a PhD in Biochemistry from Cardiff University ...

Sanofi entered into exclusive talks to sell its consumer-healthcare business Opella to Clayton Dubilier & Rice in a deal that ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

PARIS (Reuters) - Sanofi said on Monday it had entered exclusive negotiations for the sale of a 50% controlling stake in its ...

In Q3 2024, consolidated sales amounted to €6,357 million: -2.6% on a reported basis and slightly down year-on-year on an ...

Norwegian bank DNB said on Monday it had agreed to buy Carnegie Holding AB from Altor and minority shareholders for around 12 ...

UBS is offloading part of the Credit Suisse business it acquired last year with a deal to sell the fallen bank's 50% stake in ...

Recent updates in health include Hong Kong's ongoing monkey deaths due to melioidosis, Egypt's certification as malaria-free ...

This is obviously not the best of times for President Bola Ahmed Tinubu, who since assuming office on May 29, 2023, ...

France will take a stake in Sanofi’s Opella through the Public Investment Bank, or BPI, finance minister Antoine Armand said on Sunday, confirming an information from Le Figaro ...